X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs UNICHEM LAB - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH UNICHEM LAB STERLING BIOTECH/
UNICHEM LAB
 
P/E (TTM) x -1.7 29.0 - View Chart
P/BV x 0.1 3.1 2.2% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 STERLING BIOTECH   UNICHEM LAB
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
UNICHEM LAB
Mar-16
STERLING BIOTECH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs11334 3.1%   
Low Rs3174 2.0%   
Sales per share (Unadj.) Rs26.8146.9 18.2%  
Earnings per share (Unadj.) Rs-15.011.9 -125.8%  
Cash flow per share (Unadj.) Rs-5.516.2 -33.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.9105.1 52.2%  
Shares outstanding (eoy) m267.8790.84 294.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.31.7 15.0%   
Avg P/E ratio x-0.521.4 -2.2%  
P/CF ratio (eoy) x-1.315.7 -8.1%  
Price / Book Value ratio x0.12.4 5.2%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m1,86223,073 8.1%   
No. of employees `0001.45.7 23.9%   
Total wages/salary Rs m5472,558 21.4%   
Avg. sales/employee Rs Th5,303.32,352.5 225.4%   
Avg. wages/employee Rs Th403.8450.9 89.6%   
Avg. net profit/employee Rs Th-2,959.0190.4 -1,553.7%   
INCOME DATA
Net Sales Rs m7,18113,346 53.8%  
Other income Rs m43192 22.2%   
Total revenues Rs m7,22313,538 53.4%   
Gross profit Rs m9471,639 57.8%  
Depreciation Rs m2,543390 652.1%   
Interest Rs m4,37729 15,198.3%   
Profit before tax Rs m-5,9311,412 -420.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m-1,924293 -657.4%   
Profit after tax Rs m-4,0071,080 -370.8%  
Gross profit margin %13.212.3 107.4%  
Effective tax rate %32.420.7 156.5%   
Net profit margin %-55.88.1 -689.2%  
BALANCE SHEET DATA
Current assets Rs m14,3355,979 239.7%   
Current liabilities Rs m49,8092,432 2,048.1%   
Net working cap to sales %-494.026.6 -1,858.5%  
Current ratio x0.32.5 11.7%  
Inventory Days Days40363 639.6%  
Debtors Days Days17160 282.6%  
Net fixed assets Rs m55,4326,403 865.8%   
Share capital Rs m268182 147.4%   
"Free" reserves Rs m13,9359,293 150.0%   
Net worth Rs m14,7019,548 154.0%   
Long term debt Rs m9,478230 4,113.7%   
Total assets Rs m73,98812,843 576.1%  
Interest coverage x-0.450.0 -0.7%   
Debt to equity ratio x0.60 2,671.8%  
Sales to assets ratio x0.11.0 9.3%   
Return on assets %0.58.6 5.8%  
Return on equity %-27.311.3 -240.9%  
Return on capital %-6.414.3 -44.8%  
Exports to sales %25.929.2 88.6%   
Imports to sales %0.26.3 2.7%   
Exports (fob) Rs m1,8603,900 47.7%   
Imports (cif) Rs m12847 1.4%   
Fx inflow Rs m1,8604,356 42.7%   
Fx outflow Rs m251,162 2.1%   
Net fx Rs m1,8353,194 57.4%   
CASH FLOW
From Operations Rs m1,7191,119 153.6%  
From Investments Rs m-3,148-853 368.9%  
From Financial Activity Rs m1,426-334 -426.7%  
Net Cashflow Rs m-3-68 5.0%  

Share Holding

Indian Promoters % 33.9 50.1 67.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 9.9 3.0 330.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 31.7 124.0%  
Shareholders   21,482 20,176 106.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DIVIS LABORATORIES  WOCKHARDT LTD.  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue to Fall, IT Sector Growth Projections, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green but ended on a weak note. The BSE Sensex closed lower by 71 points to end the day at 33,704.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 20, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS